-
. Word, Excel, Access, Powerpoint, etc, downloading and installing software, and data file organization. Accuracy and attention to detail. Knowledge of basic laboratory safety procedures and techniques.
-
University of Toronto | Downtown Toronto University of Toronto Harbord, Ontario | Canada | about 1 month ago
procedures of the University of Toronto or other related educational institutions. Excellent analytical and numerical skills. Proficient using analytical software/spreadsheets/data visualization tools. Good
-
research Experience with clinical trials an asset Excellent communication skills Strong attention to detail Ability to exercise tact, discretion and safeguard confidentiality Comfort using MS Office software
-
for doctoral funding. Effective from the 2023-2024 academic year onwards, the IGF is also offering opportunities for (i) Indigenous PhD students in their fourth year to apply for a fifth year of fundin g and (ii
-
to Research Ethics requirements. Proficiency with computer applications such as word processing and spreadsheet software (SPSS, Microsoft Word, Excel), and internet applications and tools. Ability to administer
-
significant research component (i.e. coursework only) Doctor of Pharmacy, EDD, and DMA PhD students will not be considered for AGF Bridge funding. All PhD students who would otherwise be eligible (i.e. in
-
, knowledge, and skills related to equity, diversity, and inclusion PREFERRED QUALIFICATIONS Computer Skills Required: MS Office, data analysis software. Ability to work effectively independently and in a team
-
/PhD, DVM/PhD, JD/MA, JD/PhD, MBA/PhD, MA/MBA) as well as clinically oriented programs of study, including clinical psychology, are eligible if they have a significant autonomous research component, as
-
processing software, spreadsheet programs, presentation software, data bases and Internet Knowledge user of REDCap, MS Teams, and Microsoft Office
-
research account in Workday. Meet Award Holders Jonas Olsen Doctor of Philosophy in Pharmaceutical Sciences (PhD) Developing Novel Small Molecule Inhibitors of CLIC3 to Target Metastatic Breast Cancer Samuel